Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Legembre

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|October 13, 2017
CD95/Fas, Non-Apoptotic Signaling Pathways, and KinasesMatthieu Le Gallo, Amanda Poissonnier, Patrick Blanco, et al.
Cellular and Molecular Life Sciences : CMLS|November 2, 2011
CD95-mediated cell signaling in cancer: mutations and post-translational modulationsSébastien Tauzin, Laure Debure, Jean-François Moreau, et al.
Cells|May 14, 2022
Fas/CD95 Signaling Pathway in Damage-Associated Molecular Pattern (DAMP)-Sensing ReceptorsGael Galli, Pierre Vacher, Bernhard Ryffel, et al.
Birth Defects Research|February 1, 2019
An insight into the role of the death receptor CD95 throughout pregnancy: Guardian, facilitator, or foeLucas Sagrillo-Fagundes, Josianne Bienvenue-Pariseault, Patrick Legembre, et al.
Communicative & Integrative Biology|July 19, 2012
The CD95 signaling pathway: To not die and flyAubin Penna, Nadine Khadra, Sébastien Tauzin, et al.
The Journal of Biological Chemistry|September 4, 2004
Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasivenessPatrick Legembre, Robert Schickel, Bryan C Barnhart, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 20, 2016
Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast CancersAmélie Fouqué, Mickael Jean, Pierre van de Weghe, et al.
Microbes and Infection|March 3, 2022
Cleaved CD95L perturbs in vitro macrophages responses to Toxoplasma gondiiEllen A Tiffney, Janine L Coombes, Patrick Legembre, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Cutting edge: SDS-stable Fas microaggregates: an early event of Fas activation occurring with agonistic anti-Fas antibody but not with Fas ligandPatrick Legembre, Marie Beneteau, Sophie Daburon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
Modulation of Fas-mediated apoptosis by lipid rafts in T lymphocytesPatrick Legembre, Sophie Daburon, Patrick Moreau, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|October 13, 2017
CD95/Fas, Non-Apoptotic Signaling Pathways, and KinasesMatthieu Le Gallo, Amanda Poissonnier, Patrick Blanco, et al.
Cellular and Molecular Life Sciences : CMLS|November 2, 2011
CD95-mediated cell signaling in cancer: mutations and post-translational modulationsSébastien Tauzin, Laure Debure, Jean-François Moreau, et al.
Cells|May 14, 2022
Fas/CD95 Signaling Pathway in Damage-Associated Molecular Pattern (DAMP)-Sensing ReceptorsGael Galli, Pierre Vacher, Bernhard Ryffel, et al.
Birth Defects Research|February 1, 2019
An insight into the role of the death receptor CD95 throughout pregnancy: Guardian, facilitator, or foeLucas Sagrillo-Fagundes, Josianne Bienvenue-Pariseault, Patrick Legembre, et al.
Communicative & Integrative Biology|July 19, 2012
The CD95 signaling pathway: To not die and flyAubin Penna, Nadine Khadra, Sébastien Tauzin, et al.
The Journal of Biological Chemistry|September 4, 2004
Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasivenessPatrick Legembre, Robert Schickel, Bryan C Barnhart, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 20, 2016
Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast CancersAmélie Fouqué, Mickael Jean, Pierre van de Weghe, et al.
Microbes and Infection|March 3, 2022
Cleaved CD95L perturbs in vitro macrophages responses to Toxoplasma gondiiEllen A Tiffney, Janine L Coombes, Patrick Legembre, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Cutting edge: SDS-stable Fas microaggregates: an early event of Fas activation occurring with agonistic anti-Fas antibody but not with Fas ligandPatrick Legembre, Marie Beneteau, Sophie Daburon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
Modulation of Fas-mediated apoptosis by lipid rafts in T lymphocytesPatrick Legembre, Sophie Daburon, Patrick Moreau, et al.
Pageof 9